Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
NCT06157060
·
clinicaltrials.gov ↗
RECRUITING
Status
255
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma Resectable
Interventions
DIAGNOSTIC_TEST:
circulating tumor DNA
Sponsor
Zhujiang Hospital